Acelrx pharmaceuticals announces closing of divestment of dsuvia® to alora pharmaceuticals

In connection with closing, acelrx received approximately $2.7 million from alora pharmaceuticals and aguettant acelrx announces full repayment of its senior loan with oxford finance hayward, calif. , april 5, 2023 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), (acelrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the closing of its divestment of dsuvia® to alora pharmaceuticals (alora).
ACRX Ratings Summary
ACRX Quant Ranking